1. Rothwell, PM, Cook, NR, Gaziano, JM et al. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials. (published online July 12.)Lancet. 2018;http://dx.doi.org/10.1016/S0140-6736(18)31133-4
2. Theken, Katherine N., and Tilo Grosser. "Weight-adjusted aspirin for cardiovascular prevention." The Lancet (2018).
3. Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-
analysis of individual participant data from randomised trials. Lancet. 2009; 373: 1849–1860